AstraZeneca PLC
1543.25
22-8月-25 08:24:45
15 分の遅延
株式
-14.75
-0.95%
本日の幅
1539.00 - 1568.00
ISIN
N/A
ソース
Cboe
-
AZN And Daiichi Sankyo's ENHERTU Shows Significant Survival Benefit In Phase 3 Gastric Cancer Trial
31 5 2025 08:06:30 提供 NASDAQ US Markets
-
AstraZeneca (AZN) Shares Cross Above 200 DMA
30 5 2025 13:25:47 提供 NASDAQ Stocks
-
AstraZeneca (AZN) Shares Cross Above 200 DMA
30 5 2025 13:23:33 提供 NASDAQ US Markets
-
AZN: Imfinzi Combination Improves Disease-Free Survival In Phase III High-Risk Bladder Cancer Trial
08 5 2025 23:32:42 提供 NASDAQ US Markets
-
AstraZeneca's New Asthma Treatment Shows Strong Results In Late-stage Trials
01 5 2025 23:50:57 提供 NASDAQ US Markets
-
AstraZeneca Q1 Results Climb, Maintains FY25 Outlook; Lifts Dividend
28 4 2025 23:55:29 提供 NASDAQ US Markets
-
AZN June 2027 Options Begin Trading
24 4 2025 08:32:42 提供 NASDAQ US Markets
-
AZN June 2027 Options Begin Trading
24 4 2025 08:29:50 提供 NASDAQ Stocks
-
NetDania - New 12 months Low: ASTRAZENECA PLC
09 4 2025 00:15:01 提供 NetDania Notify
-
Relative Strength Alert For AstraZeneca
07 4 2025 11:17:02 提供 NASDAQ US Markets
-
Relative Strength Alert For AstraZeneca
07 4 2025 11:09:15 提供 NASDAQ Stocks
-
NetDania - New 12 months Low: ASTRAZENECA PLC
07 4 2025 00:15:02 提供 NetDania Notify
-
AstraZeneca And Daiichi Sankyo's Enhertu Approved In EU For Advanced Breast Cancer Treatment
03 4 2025 23:42:00 提供 NASDAQ US Markets
-
AZN Makes Bullish Cross Above Critical Moving Average
03 4 2025 12:19:41 提供 NASDAQ US Markets
-
03 4 2025 07:46:36 提供 NASDAQ US Markets
-
03 4 2025 07:27:06 提供 NASDAQ Stocks
-
AstraZeneca's Imfinzi Combo Approved In US For Muscle-Invasive Bladder Cancer Treatment
30 3 2025 23:48:35 提供 NASDAQ US Markets
-
AZN : Study Confirms TAGRISSO As Essential Therapy For EGFR-Mutated Lung Cancer Across All Stages
25 3 2025 18:46:31 提供 NASDAQ US Markets
-
24 3 2025 09:22:08 提供 NASDAQ US Markets
-
AstraZeneca To Buy Belgium's Cell Therapy Firm EsoBiotec In Up To $1 Bln Deal
17 3 2025 00:30:11 提供 NASDAQ US Markets